Chi B. Vu
Impact in
- Geriatrics and Gerontology top 0.2%
- Sirtuins and Resveratrol in Medicine
- Aging top 5%
- Genetics, Aging, and Longevity in Model Organisms
Papers in
-
- Adenosine and Purinergic Signaling 7
-
- Advanced Synthetic Organic Chemistry 6
- Synthesis and biological activity 4
- Organic Chemistry Synthesis Methods 3
- Co-authors
- Harry H. Wasserman (8 shared papers)Russell C. Petter (6 shared papers)Thomas M. Engber (5 shared papers)Gnanasambandam Kumaravel (5 shared papers)Xiaowei Jin (5 shared papers)Bo Peng (4 shared papers)Michael R. Jirousek (5 shared papers)Jill C. Milne (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (10 papers)Bioorganic & Medicinal Chemistry Letters (10 papers)Tetrahedron Letters (6 papers)The Journal of Organic Chemistry (1 paper)Hepatology Communications (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Chi B. Vu
37 papers receiving 2.6k citations
Chi B. Vu's Hit Papers
Peers
Comparison fields: 5 of 98
- Geriatrics and Gerontology 915
- Aging 83
- Physiology 136
- Organic Chemistry 510
- Molecular Biology 542
Countries citing papers authored by Chi B. Vu
This map shows the geographic impact of Chi B. Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi B. Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi B. Vu more than expected).
Fields of papers citing papers by Chi B. Vu
This network shows the impact of papers produced by Chi B. Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi B. Vu. The network helps show where Chi B. Vu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi B. Vu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Hit paper breakdown → | 2007 | 1494 |
| 2 | 1997 | 134 | |
| 3 | 2000 | 124 | |
| 4 | 2009 | 112 | |
| 5 | 1999 | 82 | |
| 6 | 2008 | 82 | |
| 7 | 2004 | 71 | |
| 8 | 2004 | 60 | |
| 9 | 2004 | 56 | |
| 10 | 2004 | 43 | |
| 11 | 1999 | 35 | |
| 12 | 2004 | 34 | |
| 13 | 2016 | 33 | |
| 14 | 1990 | 30 | |
| 15 | 2000 | 30 | |
| 16 | 2009 | 25 | |
| 17 | 2016 | 24 | |
| 18 | 1990 | 20 | |
| 19 | 1992 | 20 | |
| 20 | 2003 | 19 |
About Chi B. Vu
Chi B. Vu is a scholar working on Physiology, Organic Chemistry, Geriatrics and Gerontology, Pharmacology and Molecular Biology, having authored 37 papers that have together received 2.7k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (7 papers), Advanced Synthetic Organic Chemistry (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Protein Tyrosine Phosphatases (5 papers), Chemical Synthesis and Analysis (4 papers), Synthesis and biological activity (4 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Organic Chemistry Synthesis Methods (3 papers). The work is most often cited by research in Geriatrics and Gerontology (915 citations), Aging (83 citations), Physiology (136 citations), Organic Chemistry (510 citations) and Molecular Biology (542 citations). Chi B. Vu has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Harry H. Wasserman, Russell C. Petter, Thomas M. Engber, Gnanasambandam Kumaravel, Xiaowei Jin, Bo Peng, Michael R. Jirousek, Jill C. Milne, David P. Carney and Robert B. Perni. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, The Journal of Organic Chemistry and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.